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Three cases of imported eyeworm infection in 
dogs: a new threat for the United Kingdom
John Graham-Brown, Paul Gilmore, Vito Colella, Lyndsay Moss, Chris Dixon, Martin Andrews, 
Peter Arbeid, Jackie Barber, Dorina Timofte, John McGarry, Domenico Otranto, 
Diana Williams
In July 2016 we described the first known case of canine ocular thelaziosis in the UK in a dog recently imported from 
Romania. Here we confirm our initial diagnosis using PCR followed by sequence analysis, and we report a further 
two clinical cases in dogs with recent history of travel to Italy and France. In view of the presence in the UK of the 
vector for Thelazia callipaeda, namely Phortica spp, we discuss the significance of these three cases in the context 
of the UK government’s pet travel scheme, disease control and both animal and public health in the UK.
Introduction
Thelazia callipaeda (Spirurida, Thelaziidae) is a vectorborne, 
zoonotic nematode capable of infecting a range of mammalian 
host species including dogs, cats and human beings, as well as 
several sylvatic species.1 The risks of introducing such parasitic 
agents to the UK posed by importation and/or travel of dogs 
abroad have been raised and illustrated on multiple occasions,2–4 
while widespread media reports of large-scale illegal importation 
of dogs to the UK are clearly also of concern.
Adult T callipaeda reside in the eyes and associated tissues, 
including the conjunctival fornices, nictitating membrane, sclera 
and cornea, and the lacrimal glands of the definitive host.5 Infected 
animals show a variety of clinical presentations, from subclinical 
carriage through to mild (eg, epiphora, conjunctivitis and chem-
osis) and severe pathology including corneal ulceration, which, if 
untreated, can lead to complications including secondary infec-
tions and blindness. T callipaeda is sensitive to both milbemycin 
and moxidectin, with commercially available oral and spot-on 
applications shown to be effective treatment options.6–8
T callipaeda, also referred to as ‘the oriental eye worm’, is 
increasingly common in Europe, with autochthonous transmis-
sion confirmed in Italy, France, Switzerland, Germany, Spain, 
Portugal, Bosnia and Herzegovina, Croatia, Romania, Bulgaria, 
Hungary and Greece,9–18 with further cases reported in Belgium 
and Serbia.7 19 In some locations, such as the Basilicata region of 
Italy, infection is hyperendemic, with the reported prevalence in 
dogs exceeding 40 per cent.20 Furthermore, cases of human ocular 
thelaziosis in Spain, Italy, France, Croatia and Serbia demonstrate 
the parasite’s zoonotic potential.19 21–23
The intermediate host of T callipaeda in Europe has been 
identified as the male drosophilid fruit fly Phortica variegata.24 
These flies are both anthropophilic and zoophilic, transmitting 
the infective larval stages while feeding on lacrimal secretions.25 
Studies have shown these flies are generally located in areas of oak 
woodland, with peak activity at 20°C–25°C and 50–75 per cent 
relative humidity.26 Development within the intermediate host 
may, under optimal conditions, be as short as 14 days,25 which 
combined with a prepatent period of four to eight weeks in the 
definitive host means that the peak transmission of T callipaeda 
is typically late summer/early autumn in Mediterranean coun-
tries.5 26
The UK government’s pet travel scheme (PETS) facilitates the 
travel of dogs to and from countries in the EU without the need 
for quarantine. In its current form owners are required to fulfil a 
number of specific requirements before and during travel abroad 
in order to ensure the implementation and documentation of 
control measures designed to prevent the importation of non-en-
demic zoonotic pathogens, specifically rabies and Echinococcus 
multilocularis (https://www. gov. uk/ take- pet- abroad). Given the 
relatively free and regular movement of dogs into and out of the 
UK from mainland Europe and importation from rescue charities 
under this scheme, other pathogens, including T callipaeda, pose a 
significant threat to the UK canine population. The following case 
reports highlight the clinical, epidemiological and public health 
aspects of this disease and the implications for UK animal and 
human populations.
Case 1
A one-year-old male collie cross (17 kg) was admitted for 
neutering on March 24, 2016. While under general anaesthesia, 
nematodes (n=10) were noted on the conjunctiva of both eyes 
and were removed using atraumatic forceps. The worms were 
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not associated with pathological changes and no other clinical 
abnormalities were detected. Before discharge, the dog was given 
a single treatment with imidacloprid and moxidectin (100 and 
25 mg, respectively, Advocate Spot-On Solution for Medium 
Dogs; Bayer), which are known to be effective for ocular thelazi-
osis.7 Five nematodes were placed in a 10 per cent formalin solu-
tion and submitted to Liverpool Veterinary Parasitology Diagnos-
tics (LVPD) for identification (see below). No further parasites 
or ocular disease were detected at the five-day postoperative 
follow-up appointment.
Case 2
A 12-year-old female wire hair fox terrier (9.5 kg) presented to 
its local (UK-based) veterinary surgery on September 21, 2016 
suffering from conjunctivitis of the left eye. The dog had been 
seen 20 days previously for this complaint by a veterinarian in 
Italy when a topical course of chloromycetin (unspecified) had 
been prescribed. On clinical examination worms were detected on 
the conjunctiva of the affected eye and the animal was admitted 
for further examination. Following sedation with medetomi-
dine and butorphanol (0.24 mg, Domitor 1 mg/ml solution for 
injection, Vetoquinol UK; and 0.95 mg, Torbugesic 10 mg/ml 
solution for injection, Zoetis UK, respectively), approximately 
10 nematodes were manually recovered from beneath the nicti-
tating membrane and conjunctival sac, following which the 
sedation was reversed with atipamezole (125 µg/kg, Antisedan 
5 mg/ml solution for injection; Zoetis UK). Based on the suspi-
cion of ocular thelaziosis,6 an oral dose of milbemycin and prazi-
quantel (5 and 50 mg, respectively, Milbemax tablets for small 
dogs and puppies; Novartis Animal Health UK) was admin-
istered, and topical fusidic acid (one drop twice daily, Isathal 
10 mg/g eye drops; Dechra Veterinary Products) was prescribed 
with a seven-day course for the affected left eye. Two nematodes 
were placed in physiological saline and submitted to LVPD via 
Axiom Laboratories (Newton Abbot, Devon, UK) for identifica-
tion (see below). No further worms were detected at a seven-day 
follow-up appointment. At this time the topical course of fusidic 
acid course was extended for a further seven days, and an addi-
tional treatment with imidacloprid and moxidectin (100 and 
25 mg, respectively, Advocate Spot-On Solution for Medium 
Dogs; Bayer) was also administered. No further problems have 
been reported since.
Case 3
An eight-year-old neutered female West Highland white terrier 
(8 kg) was presented on October 31, 2016 with superficial 
corneal ulceration of the right eye of a reported duration of one 
week. The dog was otherwise clinically healthy. A seven-day 
course of topical chloramphenicol 1.0 per cent w/w eye oint-
ment (5 mm three times daily; Martindale Pharmaceuticals) 
and oral meloxicam (0.1 mg/kg once daily, Metacam 1.5 mg/ml 
oral suspension for dogs; Boehringer Ingelheim Vetmedica) was 
prescribed initially. At seven days corneal ulceration had failed to 
re-epithelialise and the decision was made to refer the case to a 
dedicated ophthalmology centre for further investigation (Veter-
inary Vision, Cumbria).
Examination with Veterinary Vision on November 9, 2016 
revealed right serous ocular discharge and increased blink rate 
indicating ocular discomfort. A Schirmer tear test (MSD Animal 
Health) confirmed increased lacrimation in the affected eye meas-
uring 25 and 18 mm/minute on the right and left, respectively. 
Right conjunctival hyperaemia, ventrolateral corneal oedema and 
superficial corneal vascularisation were detected with slit lamp 
biomicroscopy (Keeler PSL Classic; Keeler), with a ventrolateral 
break in the corneal epithelium observed (Fig 1a). The presence of 
superficial corneal ulceration was confirmed by topical applica-
tion of fluorescein stain (Fluorescein Sodium Ophthalmic Strips 
USP). No ectopic cilia, distichia or foreign bodies were visual-
ised, which could have resulted in corneal abrasion. Following 
topical application of proxymetacaine hydrochloride (one drop, 
Minims Proxymetacaine Hydrochloride 0.5 per cent w/v Eye Drop 
Solution; Bausch and Lomb), intraocular pressure (measured with 
a Tono-Pen Avia Vet; Reichert Technologies) was recorded as 
within normal reference range bilaterally.27 No abnormalities of 
the eyelids, uveal tract, intraocular lens or fundus were identified. 
No abnormalities of the left eye were detected.
Irrigation of the conjunctival fornices with sterile water 
(Sterilised Water for Injections BP; Dechra Veterinary Products) 
yielded a single worm, flushed onto the corneal surface from 
the ventral fornix. The worm was removed with a sterile cotton 
FIG 1: Thelazia callipaeda-associated pathology in the right eye of case 3 showing (a) superficial ventrolateral corneal ulceration at the 
initial point of referral, and (b) re-epithelialisation associated with ventral bulbar conjunctival hyperaemia, ventrolateral corneal oedema and 
ventrolateral superficial corneal vascularisation 21 days after flushing and removal of a single male T callipaeda specimen from the ventral 
conjunctival fornix. 
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bud, placed in 0.9 per cent sodium chloride (Aqupharm 1 Sodium 
Chloride 0.9 per cent w/v; Animalcare) and submitted to the 
University of Liverpool for identification. A course of topical 
ofloxacin (one drop four times daily, Exocin 0.3 per cent w/v eye 
drops 5 ml; Allergan) and hyaluronic acid (one drop four times 
daily, Remend Corneal Gel; Bayer) was prescribed for the affected 
right eye and oral meloxicam once daily continued for a further 
seven days.
Re-examination on November 30, 2016 (21 days post-treat-
ment) showed a significant improvement in ocular comfort 
with a regular blink rate and lack of ocular discharge. Slit lamp 
biomicroscopy revealed right ventral bulbar conjunctival hyper-
aemia, ventrolateral corneal oedema and ventrolateral superficial 
corneal vascularisation (Fig 1b). Complete re-epithelialisation 
of the ulcer was confirmed using fluorescein stain. No further 
worms were identified by examination or flushing of the eyes or 
nasolacrimal ducts. A four-week course of topical dexamethasone 
(one drop twice daily, Maxitrol eye drop suspension 0.1 per cent; 
Alcon Pharmaceutical Products) was prescribed for the right eye, 
and treatment with imidacloprid and moxidectin (40 and 10 mg, 
respectively, Advocate Spot-On Solution for Small Dogs; Bayer) 
was advised for what was suspected to be a case of ocular thelazi-
osis.8 No further problems have been reported since.
Travel history
All three cases had a history of recent time abroad in countries 
where T callipaeda is known to be endemic. The dog in case 1 had 
been imported to the UK from western Romania six weeks previ-
ously, having been initially found in Hateg, Hunedoara (45.61 N, 
22.95 E). This location is geographically consistent with previous 
autochthonous T callipaeda case reports in both domestic dogs 
and sylvatic species.28 29
The dog in case 2 had recently returned from travel to 
northern Italy, having resided at a rural location close to Milan, 
Lombardia (45.48 N, 9.85 E). T callipaeda is well established across 
the north of Italy, with hyperendemicity in the adjoining region of 
Piedmont (North West), where prevalence in dogs has been previ-
ously reported at 23.1 per cent.20 26
The dog in case 3 had spent one month in France from 
August to September 2016, having never previously travelled 
outside the UK. This travel included time in Saint Avit Loisirs, 
Dordogne (44.95 N, 0.85 E). This location is less than 10 km from 
the site where autochthonous transmission of T callipaeda was 
first reported in France,10 with a more recent study identifying 
Dordogne as a focal point for T callipaeda in southern France.30
In all three cases, all requirements specified under PETS 
were met before and during travel, including microchipping, 
rabies vaccination and a tapeworm treatment administered by a 
veterinary surgeon 24–120 hours before (re-)entering the UK. In 
all cases tapeworm treatment consisted of a single dose of oral 
praziquantel as part of a combination dewormer also containing 
febantel and pyrantel (5, 15 and 14.4 mg/kg, respectively; Drontal 
Plus Tablets; Bayer). In case 3, the owners also administered their 
routine wormer (piperazine 937.5 mg and dichlorophen 1875 mg 
orally; Beaphar UK) and a generic shop-bought flea treatment 
(unspecified spot-on) following re-entry into the UK.
Morphological identification
Specimens received by LVPD were either mounted in lactophenol, 
methylene blue clearing solution for morphological identifica-
tion or preserved in 70 per cent ethanol for molecular analysis. 
Specimens from all three cases were examined by light micros-
copy (20–40× magnification) and identified as T callipaeda 
based on the key diagnostic morphological features described 
by Otranto et al. (2003).31
All specimens possessed a buccal capsule, filariform oesoph-
agus and transverse cuticular striations (Fig 2). The position of the 
vulva in the female specimens (all specimens examined from cases 
1 and 2) was anterior to the oesophagus–intestinal junction (Fig 
3). In addition, the female specimens examined from both cases 1 
and 2 were identified as adults based on the presence of a gravid 
uterus containing first stage larvae (L1; Fig 4). A single male spec-
imen (case 3) was curved at the caudal end, which contained two 
spicules of distinctly uneven length (Fig 5). The shorter spicule 
was crescent-shaped and the anterior extremity of the longer 
spicule was blunt and broadened.
Molecular investigation via PCR and sequencing
DNA extraction from adult nematodes was performed on etha-
nol-preserved specimens using a QIAGEN DNeasy Blood and 
Tissue Kit following manufacturer’s recommendations (www. 
qiagen. com). Purified DNA was then assessed via PCR amplifi-
cation using NTF/NTR primers designed to amplify the mito-
chondrial cytochrome c oxidase subunit 1 (cox1) gene of filarial 
and spirurid nematodes to yield a 689 bp product as described 
previously.32 To confirm both species and haplotype, PCR prod-
ucts were sequenced and compared with those available in the 
GenBank database, using Basic Local Alignment Search Tool 
(http:// blast. ncbi. nlm. nih. gov/ blast. cgi). The cox1 sequences 
obtained from nematodes collected from the three dogs were 
identical to the sequence of T callipaeda haplotype-1 (h1) 
(GenBank accession no. AM042549)
Discussion
FIG 2: Light micrograph of female Thelazia callipaeda, anterior. 
BC, buccal capsule; FO, filariform oesophagus; L, L1 larvae; OIJ, 
oesophagus–intestinal junction; TCS, transverse cuticular striations; 
V, vulva (×10).
FIG 3: Light micrograph of female Thelazia callipaeda, anterior. 
Vulva (V) positioned anterior to the oesophagus–intestinal junction 
(OIJ) (×20).
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In all three instances dogs were known to have travelled to coun-
tries and regions, namely Romania, Italy and France, where T 
callipaeda populations to date have consisted exclusively of h1, as 
is the case across Europe .10 28 32 These three cases therefore demon-
strate the risk of introducing T callipaeda to the UK through dogs 
being imported from and travelling to geographical locations 
where T callipaeda is known to be endemic. Furthermore, since 
T callipaeda is zoonotic and capable of infecting several other 
mammalian species, both people and cats should also be consid-
ered at risk of infection when travelling to such areas.22 30
While fulfilling the legal requirements of PETS, the coinci-
dental administration of nematocides in the form of febantel and 
pyrantel in all cases and further treatment with piperazine and 
dichlorophen in case 3 are demonstrably unsuccessful in clearing 
T callipaeda infection. To date only milbemycin and moxidectin 
have been registered against ocular thelaziosis6 8 This represents a 
notable gap in the prophylactic measures present under PETS for 
this specific parasite, and we would encourage veterinarians to 
discuss the relevant treatment options with owners planning on 
travelling to or returning from such areas with their pets.
The clinical nature of cases 2 and 3 highlights the potential 
health and welfare issues of T callipaeda infection. Conversely, 
the subclinical carriage observed in case 1 is also of importance, 
as such infections may remain undiagnosed upon return to the 
UK. Gravid females were present in cases 1 and 2, which together 
with the presence of the vector in the UK highlights the potential 
for the parasite to become established in the UK.33 Similarly, the 
introduction of T callipaeda in a previously non-endemic region of 
Spain (La Vera) was thought to be due to hunting dogs travelling 
from endemic areas of Italy and France.13
P variegata is typically found in regions of deciduous 
(commonly oak) forest with greatest activity during warmer, 
humid periods.26 Ecological niche modelling for Europe in 2006 
identified the southern parts of England as suitable habitat 
for P variegata,26 with reports confirming its presence in 
Gloucestershire, Kent and Berkshire.34–36 Further investigation 
to establish the current distribution and population density 
of P variegata in the UK through a combination of entomolog-
ical surveillance and ecological niche modelling with up-to-date 
climate data would help to determine the current risk of T calli-
paeda becoming endemic in the UK.
In summary, these three cases of canine ocular thelaziosis 
demonstrate the potential risks posed to the UK canine popu-
lation from infection with T callipaeda through travel to and 
importation from parts of mainland Europe. Vigilance is therefore 
advised when examining travelled dogs. Although effective diag-
nostic tests and treatments are available, more can and should be 
done to prevent this zoonotic pathogen from becoming endemic 
in the UK.
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